Farah ME - Search Results

1

Association of Weight-Adjusted Caffeine and β-Blocker Use With Ophthalmology Fellow Performance During Simulated Vitreoretinal Microsurgery.

Roizenblatt M, Dias Gomes Barrios Marin V, Grupenmacher AT, Muralha F, Faber J, Jiramongkolchai K, Gehlbach PL, Farah ME, Belfort R Jr, Maia M. Roizenblatt M, et al. Among authors: farah me. JAMA Ophthalmol. 2020 Aug 1;138(8):819-825. doi: 10.1001/jamaophthalmol.2020.1971. JAMA Ophthalmol. 2020. PMID: 32525517 Free PMC article. Clinical Trial.

2

Unilateral pigmentary retinopathy associated with ocular toxoplasmosis.

Silveira C, Belfort R Jr, Nussenblatt R, Farah M, Takahashi W, Imamura P, Burnier M Jr. Silveira C, et al. Am J Ophthalmol. 1989 Jun 15;107(6):682-4. doi: 10.1016/0002-9394(89)90274-2. Am J Ophthalmol. 1989. PMID: 2729419 No abstract available.

3

Antihelminthic drugs in diffuse unilateral subacute neuroretinitis.

Casella AM, Farah ME, Belfort R Jr. Casella AM, et al. Among authors: farah me. Am J Ophthalmol. 1998 Jan;125(1):109-11. doi: 10.1016/s0002-9394(99)80248-7. Am J Ophthalmol. 1998. PMID: 9437327

4

Photodynamic therapy with indocyanine green for occult subfoveal choroidal neovascularization caused by age-related macular degeneration.

Costa RA, Farah ME, Cardillo JA, Belfort R Jr. Costa RA, et al. Among authors: farah me. Curr Eye Res. 2001 Oct;23(4):271-5. doi: 10.1076/ceyr.23.4.271.5449. Curr Eye Res. 2001. PMID: 11852428

5

Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome.

Farah ME, Costa RA, Muccioli C, Guia TA, Belfort R Jr. Farah ME, et al. Am J Ophthalmol. 2002 Jul;134(1):137-9. doi: 10.1016/s0002-9394(02)01456-3. Am J Ophthalmol. 2002. PMID: 12095828

6

Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.

Andrade RE, Muccioli C, Farah ME, Nussenblatt RB, Belfort R Jr. Andrade RE, et al. Among authors: farah me. Am J Ophthalmol. 2004 Mar;137(3):572-4. doi: 10.1016/j.ajo.2003.08.035. Am J Ophthalmol. 2004. PMID: 15013890

7

Effects of intravitreal indocyanine green injection in rabbits.

Maia M, Margalit E, Lakhanpal R, Tso MO, Grebe R, Torres G, Au Eong KG, Farah ME, Fujii GY, Weiland J, de Juan E Jr, D'Anna SA, Humayun MS. Maia M, et al. Among authors: farah me. Retina. 2004 Feb;24(1):69-79. doi: 10.1097/00006982-200402000-00011. Retina. 2004. PMID: 15076947

8

Effects of indocyanine green injection on the retinal surface and into the subretinal space in rabbits.

Maia M, Kellner L, de Juan E Jr, Smith R, Farah ME, Margalit E, Lakhanpal RR, Grebe L, Au Eong KG, Humayun MS. Maia M, et al. Among authors: farah me. Retina. 2004 Feb;24(1):80-91. doi: 10.1097/00006982-200402000-00012. Retina. 2004. PMID: 15076948

9

Retinal pigment epithelial abnormalities after internal limiting membrane peeling guided by indocyanine green staining.

Maia M, Haller JA, Pieramici DJ, Margalit E, de Juan E Jr, Farah ME, Lakhanpal RR, Au Eong KG, Guven D, Humayun MS. Maia M, et al. Among authors: farah me. Retina. 2004 Feb;24(1):157-60. doi: 10.1097/00006982-200402000-00024. Retina. 2004. PMID: 15076960 No abstract available.

10

Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.

Cardillo JA, Melo LA Jr, Costa RA, Skaf M, Belfort R Jr, Souza-Filho AA, Farah ME, Kuppermann BD. Cardillo JA, et al. Among authors: farah me. Ophthalmology. 2005 Sep;112(9):1557-63. doi: 10.1016/j.ophtha.2005.03.023. Ophthalmology. 2005. PMID: 16019075 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page